doi:10.1371/journal.pone.0273364 Fang, J., Chen, W., Hou, P., Liu, Z., Zuo, M., Liu, S., Feng, C., Han, Y., Li, P., Shi, Y., & Shao, C
People with a diagnosed B12 deficiency
The cytoplasmic domain of RAGE demonstrates a high degree of sequence conservation among primates and rodents
Next-generation therapies, which include combinations of GLP-1 drugs and other peptides, are being studied for their potential to better preserve muscle and bone compared with GLP-1 drugs alone
Clinical Trial Results: Weight Loss & Key Outcomes Phase 2 (Published in NEJM & Nature Medicine) Obesity trial (NEJM 2023): Up to 24.2% mean weight loss at 48 weeks (12 mg dose)
No Weight-loss medications like GLP-1 agonists are powerful tools, but new research in The BMJ reminds us of something many clinicians already know